Home » Topics » BioWorld Science

BioWorld Science
RSS

Sankyo reveals potential immunosupressants

July 12, 1996

Ciba-Geigy identifies antiinflammation agents

July 12, 1996

Immunosuppressive and antiinflammatory agents from Italfarmaco

July 12, 1996

SB-210313: A potent LPS-TNF production inhibitor

July 12, 1996

Antiinflammatory bone resorption inhibitors from Takeda

July 12, 1996

Bayer discloses matrix metalloproteinase inhibitors

July 12, 1996

Artemether as effective as quinine in malaria studies

July 12, 1996

COX-2 inhibitors for inflammation and/or pain from Roche

July 12, 1996

Whole-body extracorporeal hyperthermia trials enter phase II

July 12, 1996

AIDS Research Highlights (July 7-12, Vancouver)

July 12, 1996

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 30, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 30, 2025.
Researchers discover how glioblastoma tumors dodge chemotherapy
BioWorld MedTech
Researchers at the University of Sydney have uncovered a mechanism that may explain why glioblastoma returns after treatment, and the world-first discovery offers...
Shionogi nabs revenue-generating ALS drugs with $2.5B Tanabe pact
BioWorld
Shionogi & Co. Ltd. will acquire global rights to U.S. FDA approved amyotrophic lateral sclerosis therapy edaravone through a $2.5 billion acquisition deal with...
Big pharma taps fast Asia innovation in search of next Keytruda
BioWorld
Speed and innovation from Asia Pacific’s (APAC) biotechnology sector had big pharma scouring the region for the next oncology heir to Keytruda (pembrolizumab),...